Published in Leukemia on December 16, 2011
Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol (2013) 1.57
Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts. Clin Cancer Res (2014) 0.91
Molecular mechanisms of reduced nerve toxicity by titanium dioxide nanoparticles in the phoxim-exposed brain of Bombyx mori. PLoS One (2014) 0.87
Epigenetic deregulation in pediatric acute lymphoblastic leukemia. Epigenetics (2014) 0.86
DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia. Clin Epigenetics (2015) 0.85
RNA sequencing: from tag-based profiling to resolving complete transcript structure. Cell Mol Life Sci (2014) 0.83
Sense-antisense gene-pairs in breast cancer and associated pathological pathways. Oncotarget (2015) 0.79
Genome-scale technology driven advances to research into normal and malignant haematopoiesis. Scientifica (Cairo) (2012) 0.75
Deregulation of the non-coding genome in leukemia. RNA Biol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
Serial analysis of gene expression. Science (1995) 60.15
Sequencing technologies - the next generation. Nat Rev Genet (2009) 40.57
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32
The impact of next-generation sequencing technology on genetics. Trends Genet (2008) 21.07
Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics (2007) 18.19
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell (2002) 11.83
Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science (2008) 11.33
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia (2007) 10.74
Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell (2009) 10.50
Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res (2008) 10.10
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell (1998) 8.99
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature (2008) 7.64
Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature (2009) 6.88
Three abundance classes in HeLa cell messenger RNA. Nature (1974) 6.79
Next-generation tag sequencing for cancer gene expression profiling. Genome Res (2009) 6.50
The antisense transcriptomes of human cells. Science (2008) 6.29
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood (2003) 4.54
Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol (2009) 4.48
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med (2004) 4.16
Does aneuploidy cause cancer? Curr Opin Cell Biol (2006) 3.89
Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol (2008) 3.57
Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell (2010) 3.42
ASTD: The Alternative Splicing and Transcript Diversity database. Genomics (2008) 2.72
DeepSAGE--digital transcriptomics with high sensitivity, simple experimental protocol and multiplexing of samples. Nucleic Acids Res (2006) 2.66
Genome-wide in silico identification and analysis of cis natural antisense transcripts (cis-NATs) in ten species. Nucleic Acids Res (2006) 2.21
PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev (2008) 1.90
The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell (2000) 1.81
Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol (2010) 1.80
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica (2009) 1.79
Extensive relationship between antisense transcription and alternative splicing in the human genome. Genome Res (2011) 1.69
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. J Clin Oncol (2007) 1.64
The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol (2008) 1.47
DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood (2009) 1.42
Gene expression profiling of human breast tissue samples using SAGE-Seq. Genome Res (2010) 1.41
NATsDB: Natural Antisense Transcripts DataBase. Nucleic Acids Res (2006) 1.33
Sense-antisense pairs in mammals: functional and evolutionary considerations. Genome Biol (2007) 1.26
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer (2009) 1.22
SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer (2010) 1.16
Integrative analysis of the human cis-antisense gene pairs, miRNAs and their transcription regulation patterns. Nucleic Acids Res (2009) 1.15
Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood (2010) 1.14
BAD/BCL-[X(L)] heterodimerization leads to bypass of G0/G1 arrest. Oncogene (2001) 1.08
Altered antisense-to-sense transcript ratios in breast cancer. Proc Natl Acad Sci U S A (2010) 1.08
Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia. Cancer Genet Cytogenet (2009) 1.04
The emerging role of RNA in the regulation of gene transcription in human cells. Semin Cell Dev Biol (2011) 1.04
Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol (2006) 0.93
Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Genes Chromosomes Cancer (2008) 0.93
Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability. Oncogene (2010) 0.92
The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial. Leukemia (2011) 0.88
Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol Rev (2000) 0.88
Argininosuccinate synthetase gene expression in leukemias: potential diagnostic marker for blastic crisis of chronic myelocytic leukemia. Leuk Res (1992) 0.86
Protein kinase C-theta is specifically localized on centrosomes and kinetochores in mitotic cells. Biochem J (1999) 0.81
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease. Lancet (1983) 3.17
Cost analysis of the treatment of acute childhood lymphocytic leukaemia according to Nordic protocols. Acta Paediatr (2000) 2.11
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia (2009) 2.11
Computational adaptive optics for live three-dimensional biological imaging. Proc Natl Acad Sci U S A (2001) 1.91
Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ (2009) 1.67
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child (2002) 1.65
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia (2007) 1.52
Mammalian DNA ligases. Serological evidence for two separate enzymes. J Biol Chem (1975) 1.42
Prepubertal growth and growth hormone secretion in children after treatment for hematological malignancies, including autologous bone marrow transplantation. Pediatr Hematol Oncol (2000) 1.41
Prospective evaluation of Candida antigen and antibody assays for detection of Candida infections in children with malignant disease. Acta Paediatr (1995) 1.41
Isolation and characterization of calf liver thioredoxin. J Biol Chem (1974) 1.39
Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia (2008) 1.33
DNA ligases of eukaryotes. FEBS Lett (1976) 1.27
Intracellular distribution of carbonic anhydrase in the rat kidney. Kidney Int (1980) 1.24
Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophthalmol Vis Sci (1986) 1.24
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia (2012) 1.23
Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun (2010) 1.21
Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations. Leukemia (2010) 1.19
Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. Leukemia (2005) 1.18
Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia. Eur J Haematol (1999) 1.17
Accumulation of atenolol and metoprolol in human breast milk. Eur J Clin Pharmacol (1981) 1.16
Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun (2008) 1.13
Amount of introgression in flycatcher hybrid zones reflects regional differences in pre and post-zygotic barriers to gene exchange. J Evol Biol (2005) 1.10
Time of appearance of immunoglobulin-containing cells in the mucosa of the neonatal intestine. Pediatr Res (1980) 1.10
DNA ligases during rat liver regeneration. Nature (1976) 1.09
Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. Diabetologia (2007) 1.09
Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents. Acta Paediatr (2003) 1.08
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. Br J Cancer (2005) 1.05
Amount and distribution of carbonic anhydrases CA I and CA II in the gastrointestinal tract. Gastroenterology (1985) 1.04
Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Leukemia (2002) 1.03
Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer (1994) 1.03
Strand-break formation in DNA modified by benzo[alpha]pyrene diolepoxide. Quantitative cleavage by Escherichia coli uvrABC endonuclease. Mutat Res (1983) 1.02
Carbonic anhydrase in rat liver and rabbit skeletal muscle: further evidence for the specificity of the histochemical cobalt-phosphate method of Hansson. J Histochem Cytochem (1980) 1.02
Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia. Leukemia (2003) 1.01
Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases. Arch Gen Psychiatry (1985) 1.00
6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood (1998) 1.00
[Invasive Streptococcus agalactiae infections in non-pregnant adults]. Med Mal Infect (2007) 1.00
Two DNA ligase activities from calf thymus. Biochem Biophys Res Commun (1973) 1.00
Statistical evaluation of local alignment features predicting allergenicity using supervised classification algorithms. Int Arch Allergy Immunol (2004) 0.99
No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol (2001) 0.99
Morphometric and immunohistochemical study of jejunal biopsies from children with intestinal soy allergy. Eur J Pediatr (1981) 0.98
Mammalian deoxyribonucleic acid ligase. Isolation of an active enzyme-adenylate complex. J Biol Chem (1973) 0.98
Combined treatment with sustained-release theophylline and beta2-adrenoceptor-stimulating agents in chronic childhood asthma. Br Med J (Clin Res Ed) (1981) 0.98
13q deletions in lymphoid malignancies. Blood (1995) 0.97
Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant (2002) 0.95
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome? Leukemia (2000) 0.93
The potato tuber transcriptome: analysis of 6077 expressed sequence tags. FEBS Lett (2001) 0.93
High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL). Cancer Chemother Pharmacol (2003) 0.93
Whole-exome sequencing of pediatric acute lymphoblastic leukemia. Leukemia (2011) 0.92
Loss of chromosomes is the primary event in near-haploid and low-hypodiploid acute lymphoblastic leukemia. Leukemia (2012) 0.90
Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles. Eur J Haematol (2005) 0.90
Pediatric rhabdomyosarcomas express the intermediate filament nestin. Pediatr Res (1998) 0.90
Carbonic anhydrase in the human kidney: a histochemical and immunocytochemical study. Kidney Int (1984) 0.90
Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy. Pediatr Dent (1994) 0.89
Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci U S A (1993) 0.89
Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study. Med Pediatr Oncol (2002) 0.89
Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology. Cancer Chemother Pharmacol (1991) 0.89
Acquired X-chromosome aneuploidy in children with acute lymphoblastic leukemia. Med Pediatr Oncol (1999) 0.88
Carbonic anhydrase in the intestinal tract of the guinea-pig. Acta Physiol Scand (1977) 0.88
Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res (1991) 0.88
Osteogenesis imperfecta: mosaicism and refinement of the genotype-phenotype map in OI type III. Mutations in brief no. 242. Online. Hum Mutat (1999) 0.88
Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paediatr (1998) 0.88
The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial. Leukemia (2011) 0.88
Late side effects of chemotherapy in ovarian carcinoma: a cytogenetic, hematologic, and statistical study. Cancer (1982) 0.87
The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse. Leukemia (2010) 0.87
Kidneys very large at diagnosis are associated with poor prognosis in children with acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol (1986) 0.87
Phenylpropanolamine and mental disturbances. Lancet (1980) 0.87
Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer (1992) 0.87
Morphology of the jejunum in children with eczema due to food allergy. Allergy (1980) 0.86
Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL. Leukemia (2001) 0.86
Molecular cloning of Limulus alpha 2-macroglobulin. Eur J Biochem (1996) 0.86
Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986-91. Acta Paediatr (1997) 0.86
Fragility of the centromeric region of chromosome 1 associated with combined immunodeficiency in siblings. A recessively inherited entity? Acta Paediatr Scand (1990) 0.86
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities. Leukemia (2005) 0.86
Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome. Leukemia (2007) 0.85
Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients. Int J Immunopharmacol (1986) 0.85
Pulmonary function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant (2004) 0.85
Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia. Leukemia (1992) 0.85
Computational detection of allergenic proteins attains a new level of accuracy with in silico variable-length peptide extraction and machine learning. Nucleic Acids Res (2006) 0.85
Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. Br J Haematol (2005) 0.84
Carbonic anhydrase in the human fetal kidney. Pediatr Res (1983) 0.84
HCO3- secretion in rat duodenum after treatment with omeprazole and ranitidine. Scand J Gastroenterol (1987) 0.84
Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol. Med Pediatr Oncol (1996) 0.84
Carbonic anhydrase isoenzymes in the rat kidney. Effects of chronic acetazolamide treatment. Acta Physiol Scand (1986) 0.84